Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 29 August 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Rectal NSAIDs are superior to pancreatic duct stents in preventing pancreatitis after ERCP

Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography, reports the most recent issue of the Clinical Gastroenterology & Hepatology.

News image

Placement of pancreatic duct stents prevents pancreatitis after endoscopic retrograde cholangiopancreatography.

There is evidence that rectal administration of nonsteroidal anti-inflammatory drugs also prevents post-endoscopic retrograde cholangiopancreatography pancreatitis, but the 2 approaches alone have not been compared directly.

Dr Ali Akbar from Minnesota, USA conducted a network meta-analysis to indirectly compare the efficacies of these procedures.

The team searched PubMed and Embase by 2 independent reviewers to identify full-length clinical studies, published in English, investigating use of pancreatic duct stent placement, and rectal nonsteroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis.

The team identified 29 studies.

The researchers used network meta-analysis to compare rates of post-endoscopic retrograde cholangiopancreatography pancreatitis among patients who received only rectal nonsteroidal anti-inflammatory drugs, only pancreatic duct stents, or both.

The combination of rectal NSAIDs with rectal stents was not superior to either approach alone
Clinical Gastroenterology and Hepatology

Placement of pancreatic duct stents and rectal administration of nonsteroidal anti-inflammatory drugs were each superior to placebo in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.

The combination of rectal nonsteroidal anti-inflammatory drugs and stents was not superior to either approach alone.

The doctors assessed that the pooled results showed that rectal nonsteroidal anti-inflammatory drugs alone were superior to pancreatic duct stents alone in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.

Dr Akbar's team commented, "Based on a network meta-analysis, rectal nonsteroidal anti-inflammatory drugs alone are superior to pancreatic duct stents alone in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis, and should be considered first-line therapy for selected patients."

"However, these findings were limited by the small number of studies assessed, potential publication bias, and the indirect nature of the comparison."

"High-quality, randomized, controlled trials are needed to compare these 2 interventions and confirm these findings."

Clin Gastroenterol and Hepatol 2013: 11(7) :778-783
15 July 2013

Go to top of page Email this page Email this page to a colleague

 29 August 2016 
Reducing Hep B-related HCC
 29 August 2016 
Hep B immunization of infants for liver cancer
 29 August 2016 
Risk factor for post-ERCP pancreatitis
 26 August 2016 
Reasons for premature surveillance colonoscopy
 26 August 2016 
Celiac disease therapeutics
 26 August 2016 
Bleeding after endoscopic dissection-induced gastric ulcers
 25 August 2016 
Short-chain fatty acids in mixed refractory constipation
 25 August 2016 
Post-infectious IBS in C. diff
 25 August 2016 
Stool DNA test for colorectal cancer screening
 24 August 2016 
Genetics and therapy response in IBD
 24 August 2016 
Hep B after infant vaccination program
 24 August 2016 
Obeticholic acid for primary biliary cholangitis
 23 August 2016 
Colorectal cancer genetics as biomarkers
 23 August 2016 
Prognostic test for mortality after liver transplant
 23 August 2016 
Postoperative mortality in elderly with IBD
 22 August 2016 
Celiac disease in the elderly
 22 August 2016 
Laparoscopic vs open colectomy databases
 22 August 2016 
Mucosal healing and ulcerative colitis outcomes
 19 August 2016 
Dietary questionnaire for GI clinics
 19 August 2016 
Botox treatment for chronic anal fissure
 19 August 2016 
Myeloid-derived suppressor cells in GI cancers
 18 August 2016 
Gallstone formation determinants
 18 August 2016 
Age disparities in IBD therapy
 18 August 2016 
Seasonal variation in diverticulitis
 17 August 2016 
IBD activity score for routine clinical use
 17 August 2016 
Attitudes to H. pylori in primary care
 17 August 2016 
Nonselective β-blockers and mortality in cirrhosis
 16 August 2016 
Upper GI lesions in adults with IBD
 16 August 2016 
C. difficile infection and mortality when managed by GI surgeons
 16 August 2016 
HCV eradication in cirrhosis
 15 August 2016 
Predicting favorable outcomes in IBD
 15 August 2016 
Scoring system predicted microscopic colitis
 15 August 2016 
Mortality in spontaneous bacterial peritonitis
 12 August 2016 
Recurrence of resected gastric cancer
 12 August 2016 
Screening for pancreatic cancer
 12 August 2016 
Index for diagnostic accuracy of Crohn's
 11 August 2016 
Colorectal neoplasm on surveillance colonoscopies
 11 August 2016 
Bowel disease in primary care patients with bowel symptoms
 11 August 2016 
Diagnosis in covert hepatic encephalopathy
 10 August 2016 
Maintenance therapy for children with eosinophilic esophagitis
 10 August 2016 
Moderate alcohol use and insulin action in HCV
 10 August 2016 
Consensus on the management of GERD
 09 August 2016 
Pancreatitis quality of life instrument
 09 August 2016 
Gallstone disease and NAFLD
 09 August 2016 
Steroid dependency and IBD
 08 August 2016 
Venous thromboembolism in celiac disease
 08 August 2016 
C. diff in IBD 
 08 August 2016 
Gut-directed hypnotherapy vs low FODMAP diet in IBS
 05 August 2016 
Therapy for H.pylori treatment
 05 August 2016 
Obesity and the development of NAFLD
 05 August 2016 
Obesity and CVD in celiac disease
 04 August 2016 
Bleeding after endoscopic resection of colorectal lesions
 04 August 2016 
Novel risk factor for post-ERCP pancreatitis
 04 August 2016 
Ondansetron for children with acute gastroenteritis
 03 August 2016 
Post-colonoscopy complications
 03 August 2016 
IVF in women with IBD
 03 August 2016 
Post-operative pancreatic fistulae after pancreatic surgery
 02 August 2016 
H. pylori in children
 02 August 2016 
Gastric cancer in patients with gastric intestinal metaplasia
 02 August 2016 
Behavioral changes and bariatric surgery

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us